RXRX – recursion pharmaceuticals, inc. - class a (US:NASDAQ)
Stock Stats
News
Recursion: Nvidia Sells Out, Collaboration Still Alive, Data Ahead [Seeking Alpha]
Recursion's REC-4881 Milestone And Cash Runway Shift Risk Reward Profile [Yahoo! Finance]
Recursion Pharmaceuticals (RXRX) was upgraded by Wall Street Zen from
Recursion Pharmaceuticals (RXRX) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $8.00 price target on the stock.
Recursion Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]
Form 144 RECURSION PHARMACEUTICAL Filed by: Borgeson Blake
Form S-8 RECURSION PHARMACEUTICAL
Form 424B5 RECURSION PHARMACEUTICAL
Form 10-K RECURSION PHARMACEUTICAL For: Dec 31
Form 8-K RECURSION PHARMACEUTICAL For: Feb 25
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.